Wellthy Therapeutics - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2015, Wellthy Therapeutics operates in Enterprise Tech industry. Initially focusing on diabetes management, the company has expanded its platform to address other chronic illnesses by integ...
Funding stage:
Venture Round
Last funding:
15/12/2020
Total funding:
$7.61 Mn+
Revenue:
Investors
Employee count:
56
Last 90d
56
Last 90d
Web traffic:
1.49K
1.49K
Last 30d
Last 30d
Wellthy Therapeutics: Funding Highlights
Funding highlights of Wellthy Therapeutics and a snapshot of its key metrics.
Total Funding$7.61 Mn+
Current StageEarly Stage
Total Round(s)6
Funding Rounds
FAQs on Funding of Wellthy Therapeutics
An Enterprise Tech Funded Wellthy Therapeutics has raised a total funding of $7.61 million as of 16 December 2020 across 6 rounds. Find the details around funding rounds, participating investors, and other insights of Wellthy Therapeutics here...
Wellthy Therapeutics has raised a total of $7.61 million across 6 funding rounds and the last round was raised on 16 December 2020.
Wellthy Therapeutics's key investors include growX ventures, BEENEXT, Cipla and 2 others.
Wellthy Therapeutics's latest funding round was an undisclosed amount in Early Stage, raised on 16 December 2020.
Wellthy Therapeutics is at the Early stage. Its most recent round was raised on 16 December 2020.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links